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a b s t r a c t
Despite the continuing developments of improved medical devices and increasing operator
expertize, coronary chronic total occlusion (CTO) remains as one of the most challenging
lesion subsets in interventional cardiology. Percutaneous coronary intervention (PCI) of CTO
is a complex procedure carrying the risk of complications that are responsible for signiﬁcant
morbidity and mortality. The complications can be classiﬁed as coronary (such as coronary
occlusion, perforation, device embolization, or entrapment); cardiac non-coronary (such as
periprocedural myocardial infarction); extra cardiac (such as vascular access complications,
systemic embolization, contrast-induced nephropathy, and radiation-induced injury). Fur-
ther, certain complications (such as donor vessel dissection or thrombosis) are unique to
CTO–PCI. There are also complications related to specialized techniques, such as dissection/
reentry and retrograde crossing techniques. A thorough understanding of the potential
complications is critical to mitigate risk during these complex procedures.
# 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic total occlusion (CTO) remains one of the most difﬁcult
subsets for the interventionists because of the perceived
procedural complexity. Over the past few years, tremendous
improvement in percutaneous coronary intervention (PCI)
materials and equipments, as well as growth of new strategies
have enabled us to treat with success even complex CTO. As
PCI of CTOs are among the most complex procedures, it
is critical to understand the potential complications with these
procedures, and steps that could be taken for mitigating risk.
Even in high volume and experienced centers, death mayE-mail address: dr_dash2003@yahoo.com.
http://dx.doi.org/10.1016/j.ihj.2016.03.009
0019-4832/# 2016 Cardiological Society of India. Published by Elsevier 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).occur in up to 1% of patients, and in-hospital myocardial
infarction (MI) may occur in up to 5% of cases, despite the
conviction that PCI of CTO is a low-risk procedure.1 There has
been a progressive decrease in periprocedural MI and rate of
death reﬂecting the evolution of PCI techniques, the develop-
ment of dedicated equipments, and the utilization of adjunc-
tive pharmacological therapy.2 A systematic review by Patel
and colleagues3 of 65 studies with 18,061 patients and 18,941
target CTO vessels also revealed low risk for death (0.2%),
emergent coronary bypass graft (0.1%), stroke (0.01%), MI
(2.5%), and contrast nephropathy (3.8%). An analysis of 3482
patients and 3493 target CTO lesions from a total of 26 studies4
revealed the complications consistent with above-mentionedB.V. This is an open access article under the CC BY-NC-ND license
Table 2 – Proposed classification of coronary perforation.
Type Deﬁnition
I Focal extraluminal crater without extravasation
II Pericardial or myocardial blush without an exit
hole larger than 1 mm
III Frank streaming of contrast through an exit hole
larger than 1 mm
IV Contrast spilling directly into anatomic cavity
chamber such as coronary sinus and the right
ventricle
V Distal perforation related to the use of
hydrophilic and/or stiff wires






Donor vessel dissection 2%
Stroke 0.5%
MI 3.1%
Q wave MI 0.6%
Vascular access complications 2%
Contrast nephropathy 1.8%
Wire fracture and equipment entrapment 1.2%
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 7 3 7 – 7 4 6738study (Table 1). For didactic purpose, CTO-related complica-
tions could be classiﬁed according to timing (acute and long
term) and according to location (cardiac coronary, cardiac non-
coronary, and extracardiac).
2. Acute coronary complications
2.1. Perforations
Coronary perforation occurs when dissection or intimal tear
propagates outward to completely penetrate the arterial wall. It
is one of the most dreaded complications of CTO–PCI which
can lead to cardiac tamponade necessitating emergency
pericardiocentesis and rarely, cardiac surgery to be controlled.
Although perforations are common in CTO–PCI (27.6%) in one
series,5 most of them do not lead to serious consequences, and
the risk of tamponade is low (approximately 0.5%). The risk
factors predictive of perforation include the use of oversized
compliant balloons (balloon-to-artery ratio >1.2) coupled with
relatively high inﬂation pressure and hydrophilic and stiffer
wires, particularly in calciﬁed and tortuous arteries.6–9 Use of
debulking such as rotational atherectomy is an additional risk of
perforation. Balloon advancement or dilatation on a subintimal
wire results in major blood extravasation which may cause
pericardial effusion possibly leading to cardiac tamponade,
intramural hematoma or iatrogenic ﬁstula between the coro-
nary and cardiac cavity.10 Balloons and equipments are
advanced in subintimal space in antegrade or retrograde
dissection and reentry in CTO–PCI. To avoid complications,
operators need to make sure that equipments are within the
adventitia, not in side branches and to size balloons appropri-
ately using intravascular ultrasound (IVUS). Ellis-graded per-
forations fall into severity, ranging from small endovascular
leaks into the adventia (type I) to frank extravasation into the
pericardial space (type III).6 Type IV include perforations into an
anatomic cavity, such as the coronary sinus and right ventricle.
Muller and colleagues, introduced type V perforation: distal
perforation related to use of hydrophilic and/or stiff wires.11 A
proposed classiﬁcation of perforation is shown in Table 2.1,11
Type I perforations rarely lead to tamponade compared to type
III perforations that are associated with a high rate of
hemodynamic compromise (due to tamponade).
2.1.1. Prevention and treatment
Prevention and minimization of the risk of bleeding is critical
which can be accomplished in using unfractionated heparinfor anticoagulation in contrast to bivalirudin and not using
glycoprotein IIb/IIIa inhibitors during the procedure. With high
activated clotting time (ACT), better anticoagulation can be
achieved with heparin than bivalirudin. In addition, bivalir-
udin does not work in stagnant columns of blood which occurs
in large bore guiding catheters leading to catheter thrombosis.
Perforation has become important particularly with introduc-
tion of stiff wires for penetrating the proximal or distal cap of
CTO. Dilatation of subintimal channel may result in vessel
occlusion or perforation. It is also important to pay careful
attention to tip hydrophilic wire (due to its propensity for
subintimal passage and perforation of end capillaries) during
attempts to deliver equipment; exchange a stiff or hydrophilic
wire for a workhorse wire immediately after conﬁrmation of
successful crossing. The possibility of wire dissection can be
avoided by meticulous angiography including dual injections
and observing the wire path in orthogonal projections. Stiff
guidewires induced perforation are of two types: perforation in
the false lumen during wire advancement into false lumen;
and distal small branch perforation after crossing the CTO
lesions. Careful observation via angiogram is the most
important consideration in diatal small branch perforations.
These perforations very often cause delayed tamponade
because operators are not able to detect them. It is advisable
to use low balloon-artery ratio, high-pressure initial balloon
inﬂation and over-sizing in heavy calciﬁcation. After initial
balloon inﬂation, the deﬂated balloon should be kept in place;
ECG should be watched for its reversal to baseline. The patient
should be asked if there is relief of chest pain after balloon
deﬂation. With a small contrast injection, if there is good distal
ﬂow without obvious extravasation of contrast, then the
balloon should be pulled back in the guidewire to be reinﬂated
should perforation occurs.12
In type I perforations, treatment is limited to careful
observation for 15–30 min with repeated injections of contrast
media. No further action is required if degree of extravasation
does not increase or diminishes. However, increased extrava-
sation is treated with reversal of anticoagulation and/or
prolonged balloon inﬂation at or proximal to the perforated
segment. Treatment of type II and III perforation should start
with inﬂation of balloon over the site of perforation to occlude
the ﬂow (prolonged inﬂation of 10–30 min usually at 2 atm).12
However, this attempt is sometimes difﬁcult to continue
because of ischemia (uncommon in CTO–PCI due to presence
of collaterals). To relieve chest pain and avoid ischemia to
distal area during balloon inﬂation, a microcatheter over
another guidewire is positioned distal to site of perforation and
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(microcatheter distal perfusion technique).13 In case of life-
threatening bleeds, reversal of heparin with protamine is
indicated only after removal of all equipments from coronary
artery. Infusion of fresh frozen plasma is the only means of
reversing anticoagulation with bivalirudin. Some patients
would require intravenous ﬂuids, vasopressors, and urgent
pericardiocentesis. Initial standard balloon catheter inﬂation
is performed at site of perforation for at least 5–10 min for
preparation of a perfusion balloon catheter and performing
pericardiocentesis. Subsequent serial prolonged balloon inﬂa-
tion (for 20–30 min) may successfully seal the perforation or
can provide time to prepare a polytetraﬂuoroehylene (PTFE)
covered stent (Fig. 1). 7-F guiding catheter is ideal as the PTFE
covered stent is bulky, rigid, and difﬁcult to deliver. It may be
difﬁcult to negotiate through previously deployed stents,
necessitating techniques such as distal anchor and use of
delivery catheters, such as Guideliner catheter (Vascular
Solutions, Minneapolis, MN).14 It frequently requires dual
guide technique to minimize bleeding in to the pericardium
while preparing for cover stent delivery and deployment.15
This technique involves contralateral access and use of a
separate guide catheter to deliver stent. A second guidewire is
advanced just proximal to the occluding balloon, which is then
deﬂated and retracted, allowing passage of new guidewire and
covered stent for complete closure of the perforation.12,15
These PTFE-covered stent demonstrated quite high stent
thrombosis rate (5.7%) and angiographic retstenosis (32%) in
various clinical settings.16 Even mild tortuosity may hamper
the positioning this stent because of rigidity due to double-
stent structure. The MGgurad stent (InspireMD, Tel Aviv,
Israel) is a bare metal stent (BMS) covered by ultrathin polymer
(polyehylene terephthalate) mesh sleeve on its external
surface. The wrapping net of this stent is designed to diffuse
stent pressure on the vessel wall, so in the site of perforation
the net compresses homogeneously on the ruptured layers.17
Yet this stent is not designed to fully cover the vessel wall. The
pericardial covered stent (PCS, ITGI Medical, Or Akiva, Israel)Fig. 1 – Bailout of Ellis type III perforation during left anterior de
intervention. (A) Type III perforation in 50-year-old gentleman a
(B) Final result after Graftmaster (Abbott Vascular, USA) coveredhighly deliverable balloon expandable fully covered stent
allowing prompt deployment in case of emergency.18 The PK
Papyrus (Biiotronik, Berlin, Germany) is a sixth generation BMS
of cobalt-chromium alloy, thinner struts of which allow
exceptional ﬂexibility and deliverability, even in challenging
vessels (Fig. 2). The polyurethane covering the stent is only
90 mm thin resulting in 24% reduction in diameter over a
sandwich design. It is 5-F and 6-F compatible, thereby
eliminating the need to switch access catheters during the
emergency situations. Type II and III perforations unrespon-
sive to the above measures would require emergent cardiac
surgery. Type IV perforation usually does not require treat-
ment. Type V perforations resulting from distal guidewire
manipulation should ﬁrst be treated by proximal balloon
inﬂation. Alternatively, and particularly in case of persistent
leakage, embolization may be considered with microcoils,
gelfoam, clotted autologous blood, thrombin, polyvinyl
alcohol, and subcutaneous tissue.12,17,19 When injecting
material in a perforated artery, care must be taken to prevent
spilling the material in other coronary arteries or branches by
inﬂating a balloon proximal to the injection site, or injecting
through the distal lumen of an inﬂated over-the wire-balloon.
2.2. Aortocoronary dissection
Aortic dissection may complicate any PCI, but is common with
CTO–PCI and most frequently occurs in right coronary artery. It
could be the result of guiding catheter trauma (large-caliber
guide catheter with aggressive shapes, such as Amplatz),
forceful contrast injection through a wedged catheter, or by
balloon rupture.12,14 Dissection may be limited to the coronary
sinus of valsalva, may extend to the proximal ascending aorta,
or extend beyond the ascending aorta (Table 3).20 Use of guide
catheters with side holes and/or avoiding contrast injection
during damped pressure may prevent this complication. Once
the dissection occurs, it is important to stop further coronary
injections and stent the ostium of the coronary artery.
Extension of the dissection into proximal ascending aorta ofscending (LAD) coronary artery chronic total occlusion (CTO)
fter deployment of drug-eluting stent (DES) in mid LAD.
 stent has been deployed.
Fig. 2 – Bailout of Ellis type III perforation in left circumflex (LCx) artery CTO intervention. (A) Type III perforation in distal LCx
after in-stent balloon dilatation. (B) Deployment of PK Papyrus (Biotronik, Berlin, Germany) covered stent after advancement
of Graftmaster stent has failed. (C) Final result.
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stenting of the coronary ostium with conventional stent or
covered stent (Fig. 3). Dissection extending beyond 40 mm into
aortic root, development of aortic regurgitation, and involve-
ment of supra-aortic vessels would require emergent sur-
gery.12,20
2.3. Distal vessel dissection
Distal dissection occurs when wire crossing in subintimal
position causes hematoma that compresses the true lumen. IfTable 3 – Classification of iatrogenic aortic dissection.
Class Description
1 Limited to ipsilateral coronary
sinus of sinus of Valsalva
2 Extending to the proximal
ascending aorta (<40 mm)
3 Extending beyond the proximal
ascending aorta (>40 mm)reentry fails, it may be best to wait for 2–3 months before
reattempting PCI, to allow time for healing of the dissection.
IVUS may be performed and stenting is considered in case of
tissue ﬂap or ﬂow limitation.12
2.4. Air embolism
Introduction of air into the coronary artery is potentially
dangerous, resulting in 'air lock', causing abrupt occlusion of
the vessel, possible cardiac arrest and/or MI. It occurs due to
incomplete aspiration of catheters, entry of air into manifold
system during the change of contrast, balloon rupture, and
insinuation of air with balloon catheter introduction.21 Air
embolism is more common in CTO–PCI than non-CTO–PCI
because of frequent exchange of devices, prolonged duration of
procedure, engagement of catheters in occluded segments, or
dissection planes and ‘‘trap balloon’’ technique. Its occurrence
could be prevented by careful aspiration of catheters, especially
in the setting of trap balloon that sucks air and meticulous
ﬂushing of coronary equipment. Once air lock develops, therapy
may include ventilation with 100% oxygen intravenous ﬂuids,
atropine ionotropic agents, intaaortic balloon counterpulsation,
Fig. 3 – Aortocoronary dissection after stenting of mid LAD with DES. (A) Coronary angiography depicting chronic total
occlusion (CTO) of mid LAD. (B) Good collateral from right coronary artery to LAD. (C) The CTO crossed with coronary
guidewire. (D) Predilatation of the lesion with 2.5 mm T 12 mm balloon. (E) Dissection of left main coronary artery (LMCA)
with retrograde extension into aorta following deployment of 3.0 mm T 24 mm DES in mid LAD. (F) LMCA stenting with
4 mm T 23 mm DES sealing the entry point of dissection. (G). Final result after high-pressure in-stent dilatation with non-
compliant balloon.
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the air bubbles, guidewire disruption of distal air bubbles,
extraction of bubbles with thrombectomy catheters, or over-
the wire balloon (Table 4).21
2.5. Device embolization or entrapment
A tortuous and calciﬁed coronary anatomy increases rigidity
posing challenges in device delivery in CTO vessels. Stent
loss22 or wire entrapment23 may ensue the risk of which may
be increase during retrograde wiring and stent delivery.
Adequate vessel preparation is critical prior to attempting toTable 4 – Treatment of air embolism.
 Ventilation with 100% oxygen
 Intravenous ﬂuids, atropine or vasopressors for hemodynamic
support
 Intraaortic balloon counterpulsation
 Wire or balloon catheter to induce 'air lock' dissipation
 Catheter aspiration of air embolus
 Forceful injection of saline or contrast
 Treatment of no-reﬂow phenomenon with standard
vasodilators (adenosine, verapamil, nitroprusside)
 Emergency CABGdeliver stents. Wire entrapment may be avoided by never
rotating the wire >1808 in one direction, and may sometimes
be relieved by superselective injections of nitrogycerine or
verapamil via mirocatheter. Knuckle wire should be pushed,
but never rotated for fear of wire knotting. It is important that
tip of antegrade and retrogarde microcatheters over the same
wire should not kiss to avoid entrapment. Overtorquing of
microcatheters should also be avoided. The embolized stent
could be retrieved using various snares.24 Often crushing or
deployment of lost stent with balloon or stent is more efﬁcient
than retrieval (Table 5).21 Wire braiding technique (removal of
stent with two twisted wire) and inﬂation of small balloon
distal to the stent with subsequent removal of whole system
may also be employed.21Table 5 – Management of stent embolization.
 No treatment for peripherally embolized small stents
 Deployment of the stent with balloon or second stent if on
wire
 Crushing of the stent if off wire
 Retrieval with a snare
 Removal with twisted wires
 Inﬂation of a small balloon distal to the stent and removal of
the whole system
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Antegrade dissection and reentry is an essential component of
CTO–PCI. The subintimal tracking and reentry (STAR) and
contrast-guided STAR are subject to relatively high rates of
perforation and restenosis (Table 6), because of need for
stenting long segment of the artery.25 These techniques may
also carry higher risk of periprocedural MI and restenosis
because of occlusion of side branches. Use of these techniques
is suboptimal in the left anterior descending artery where
numerous side branches (septals and diagonals) could be
sheared off and not recovered.26 In one study, a successful
STAR technique was associated with a 57% of reocclusion rate.27
Reentry leads to loss of distal visualization of the segment by
compressive hematoma. This can be prevented by avoiding
creation of a large subintimal space (with antegrade injection),
aggressive wire manipulation, or extended knuckling.
Recent technologies, ‘‘CrossBoss’’ catheter, Stingray bal-
loon, and Stingray reentry guidewire (Boston Scientiﬁc, Natik,
MA) have addressed the limitations of wire-based reentry
methods and have provided a reproducible method for
successfully gaining reentry into the true lumen of artery.
With STAR, the operator tries to gain subintimal wire position
as soon as possible, and extends a dissection to the distal
artery where all signiﬁcant-sized individual side branches are
sequentially attempted to be reconnected to the true lumen.
With ‘‘CrossBoss’’ catheter and Stingray reentry devices, over
one-third of cases can be traversed via the true lumen with the
crossing catheter without dissection. In case of subintimal
position, this catheter is advanced only to the angiographic
true lumen reentry point where the reentry device is employed
to regain the true lumen without extending the dissection anyTable 6 – Comparative complications of chronic total










Main vessel perforation ++ ++ +
Distal wire perforation ++ + +
Collateral perforation  ++ 
Aortic dissection ++ ++ 
Side branch occlusion ++ + 
Air embolism ++ + 
Donor artery thrombosis + ++ 
Stent loss + ++ 




Systemic embolism + ++ 
Radiation injury ++ ++ +
In-stent restenosis ++ ++ +
Stent thrombosis ++ ++ +
Coronary aneurysm + ++ 
Contrast nephropathy + ++ 
The complications of various techniques have been graded such as
'absent' (), 'may be' (), uncommon' (+), and common (++),
according to the rationale explained in the text. CTO, chronic total
occlusion; PCI, percutaneous coronary interventions.further than necessary. Reentry is attempted in a major
epicardial vessel rather than into individual branch vessels.
The author considers STAR a method of last resort to open a
CTO and this dedicated system as a frontline device after
conventional wire failure. If a hematoma forms due to
subintimal wire entry, aspiration through a microcatheter
may decompress the hematoma and allow reexpansion of the
distal true lumen (Subintimal TRAnscatheter Withdrawal
[STRAW] technique).26
3. Complications pertaining to the retrograde
approach
3.1. Donor artery injury
There is an augmented risk of donor artery injury owing to
spasm, dissection, or thrombus formation. This complication
is observed during antegrade approach of recanalization of
CTO as well, when donor artery angiography is performed to
visualize the distal segment distal to the occlusion via
collaterals, but risk is higher with the retrograde approach.
Equipment withdrawal or externalization of snared wire may
cause the guide catheter to deeply engage the vessel leading to
dissection. Given the typical longer duration of CTO proce-
dures, and having microcatheters in the vessel, CTO–PCIs are
more susceptible to donor artery thrombosis (Table 6). Back
bleeding and good ﬂushing should be allowed after removal of
any equipment. ACT should be monitored at least every
30 min to maintain it in between 300 and 350 s. Stenting of
donor artery should be done in case of dissection. Aspiration
thrombectomy and additional IIb/IIIa inhibitors might be
required with donor vessel thrombosis.10
3.2. Collateral channel injury
Complications exclusive to the retrograde approach are
guidewire and balloon kinking or entrapment into collateral
channel (CC), dissection, perforation, and hematoma forma-
tion (Table 6). Many CC ruptures are benign and do not require
further treatment apart from abandoning that CC and trying
for another. The channel dilator ([Corsair] Ashahi Intec, Japan)
is safer than a balloon and rarely causes CC dissection or
perforation even with excessive tortuosity. While advancing
the channel dilator, if septal wire shows excessive kinking, the
wire needs to be withdrawn to prevent septal perforation.
Septal perforations usually do not lead to adverse conse-
quences, although septal hematomas28 and even tamponade29
have been reported. In one case report, septal hematoma
manifesting as an echo-free space caused asymptomatic
bigemini and severe chest pain, and resolved spontaneously.30
Perforation into cardiac chamber usually does not result in
complications; however, balloon dilatation or advancement of
additional device should be avoided.
Epicardial CC perforation can rapidly lead to tamponade
and may be difﬁcult to control. These CC should never be
dilated to minimize the risk of perforation. Epicardial collateral
wiring is safer in patients with prior CABG or other surgery
requiring pericardial entry, as bleeding may be contained
within pericardial space.
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manipulation through CC, ensuring position of wire prior to
advancement of channel dilator, cautious injection of contrast
through its tip ensuring that back bleeding is possible prior to
injection of contrast, withdrawing epicardial collateral wire
after ascertaining no perforation at the end of procedure,
avoiding surﬁng the epicardial CC. Negative pressure from the
wedging microcatheter or channel dilator might sometimes
be sufﬁcient to seal the ruptures. Advancing microcatheter
and coiling from both sides that feed the collateral might to be
required to address perforations.14 It is advisable to perform
dual contrast injection from both sides to conﬁrm that there is
no bleeding from the antegrade or retrograde side.
3.3. Wire externalization-related problems
In retrograde true lumen puncture or reverse controlled
antegrade or retrograde subintimal tracking technique (CART),
the crossing wire is exchanged for externalization wire after a
microcatheter or channel dilator is delivered into antegrade
guide catheter. The wire used for externalization needs to be as
long as possible. Extending short guidewires is unadvisable for
this purpose because of the possibility of kinking or separation.
The wire should be lubricious and kink-resistant but not so
supportive as to damage tortuous and fragile CC. In general, a
330 cm RG 3 (Ashahi Intec, Japan) guidewire is preferable.
Avoidance of deep throating of retrograde guide catheter to
prevent ostial damage is of utmost importance during
externalization. CC needs to be protected with a microcatheter
or channel dilator. Flushing after reverse CART can result in
hydraulic dissection. Ballooning and stenting is performed after
20–30 cm wire is externalized. Distal landing zone for stents is
identiﬁed by retrograde contrast injection. The stiff part of the
wire should be under cover of channel dilator or microcatheter.
The end of the externalized wire should never be pulled unless
the CC is protected.31 To remove the externalized wire, the
channel dilator should be renegotiated into the antegrade guide
catheter. It must protect the CC until the soft wire tip is back. In
order to avoid ostial dissection because of externalized wire
retraction, both antegrade and retrograde guide catheters are
disengaged from the coronary ostium and pulled back 3–4 cm
into aorta. This follows removal of externalized wire synchro-
nized with heart beat taking care not to kink it. Then channel
dilator is removed with clockwise rotation.31
Sometimes retrograde advancement of wire into antegrade
guide catheter fails in event of aorto-ostial lesions, extremely
tortuous artery, or whenever there is poor retrograde wire con-
trol. This difﬁculty in antegrade wiring is overcome by snaring. It
is best to snare the tip or soft part of the wire. Snaring on the
stiffer part of externalization wires leads to kinking that can
shear the antegrade guide tip. The wire is gently swept into the
antegrade guide and taken care not to unravel the coils. Snaring
of polymer jacketed wire strips off the polymer. Therefore, back
bleeding is of paramount importance after externalization.
4. Acute noncoronary cardiac complications
Post-procedural MI is an infrequent complication of CTO–PCI
caused by various mechanisms such as side branch occlusionat or proximal to the CTO; CC occlusion or injury; injury of the
target vessel distal to CTO segment caused by subintimal wire
passage and/or stenting; donor vessel injury and/or thrombus
and air embolism as discussed earlier.14
5. Acute extra-cardiac complications
5.1. Vascular access injury
The probability of vascular access complications is increased
with CTO–PCI as compared to regular PCI, given larger sheaths
and dual access. The risk of such complications could be
minimized by a combination of radial and femoral access, bi-
radial approaches,32 micropunture technique, utilizing ﬂuoro-
scopic landmarks, or ultrasound33 prior to obtaining femoral
access. Retrograde CTO–PCI may be associated with higher
rate of post-procedure enzyme leak, but it is unclear if it
impacts on clinical outcome.
5.2. Contrast-induced nephropathy (CIN)
CTO–PCI entails a signiﬁcant risk as the long procedure
requires large contrast volume, and often a second or third
attempt is required for successful recanalization.34 Patients
with high risk of CIN should be identiﬁed wherein utilization of
contrast needs to be monitored closely. The ﬁrst line of
prevention consists of strict limitation of contrast amount and
avoidance of repeated use of contrast within a short period of
time.35 Other prophylactic modalities could be adequate
hydration, iso-osmolar contrast, and/or sodium bicarbonate.
5.3. Radiation injury
CTO–PCI, typically due to longer time involved, is one of the
predictors of radiation dose. Radiated-related injury, acute
(mainly skin injury) or delayed (increased risk for cancer and
cataract), has been recognized in both the patient and the
operator.36 Radiation skin injury could be a deterministic,
dose-dependent complication of CTO procedure.37,38 It is
critical to follow air kerma, and not just the ﬂuoroscopy time
as has been traditionally done. Risk of skin injury is signiﬁcant if
more than 5-Gy air kerma doses is administered. It is certainly
worthwhile considering stopping the procedure if CTO is not
crossed by 7 Gy. It is important to have a standardized radiation
safety program in place while embarking on CTO program.
Several measures can be taken to minimize radiation exposure
during CTO–PCI.14,39
1) Limit ﬂuoroscopy use
2) Limit use of cine-angiography
3) Utilizing low magniﬁcation
4) Utilizing collimation
5) Use of lowest frame rate
6) Frequent rotation of image intensiﬁer
7) Paying attention to the position of the table and image
intensiﬁer.
8) Avoidance of steep angles
9) Injecting CTO collateral donor vessel before starting cine-
angiography









MI (%) CABG (%) Tamponade
(%)
Suero et al.45 (MAHI) 2001 2007 69.9 0 1.3 2.4 0.7 0.5
Prasad et al.2 (Mayo Clinic) 2007 482 70 0 0.4 8 1.7 0.8
Kimura et al.46 2009 224 90.6 62.6 NR 4.5 0.4 NR
Rathore et al.5 2009 83 86.2 100 0 4.5 0 1.1
Tsuchikane et al.47 2010 93 96.8 100 0 5.4 0 NR
Morino et al.48 (J-CTO) 2010 498 87.7 25.7 0 2.3 0 0.4
Galassi et al.49 (ERCTO) 2011 234 64.5 100 0.4 2.1 0 0.8
Abbreviations: CABG, coronary artery bypass graft; CTO, chronic total occlusion; ERCTO, European CTO club; J-CTO, Japan CTO Club; MAHI, Mid
America Heart Institute; NR, not reported.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 7 3 7 – 7 4 674410) Use of radiation monitor providing real time feedback on
operator radiation exposure
11) Use of additional shielding, such as X-drape (AADCO
Medical, Randolph, VT)
12) Paying continuous attention to the air kerma radiation
dose and using it for modifying procedural plan.
13) Separating procedural attempts by adequate time inter-
vals.
6. Long-term complication
Patients undergoing PCI of CTO can have the same late
complication (in-stent restenosis and stent thrombosis) that
patients with non-CTO–PCI might have. Coronary aneur-
ysms40 have been reported as a late complication which is
more common in retrograde interventions as compared to
antegrade.41
7. Complication rates from published studies
Saito42 reported the dissection or minor perforation of the
target artery or CC in 13% of cases. Sianos et al.43 described
septal rupture and hematoma, MI, transient ischemic attack,
and wire entrapment in 6.9%, 4%, 0.6%, and 0.6% respectively.
Wu et al.44 described the occurrence of cardiac tamponade and
donor vessel dissection in 3.5% and collateral perforation in
3.5% cases. No patient in their series experienced death and
emergent CABG. Several other series have also reported
acceptable complications of CTO–PCI (Table 7).
8. Conclusion
CTO is the last frontier in the ﬁeld of interventional cardiology.
Despite the development of new devices and techniques,
certain complications still persist. Improved success rate in
CTO–PCI should be in conjunction with the least possible risk
of complications. Avoidance of the complications is best
accomplished by operator expertise and preventive
approaches. Having the thorough understanding of potential
complications is the ﬁrst step in mitigating the risks.
Treatment should be instituted rapidly and aggressively once
complications are recognized to achieve the best outcome. Nomatter how experienced the operator is, complications can
never be completely avoided, rather they would teach humility
and be a continuous source of education.
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